Tag: BIND

Finance

Stocks in Focus : BIND Therapeutics (NASDAQ:BIND), Bristol-Myers Squibb (NYSE:BMY), TC PipeLines (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals (NASDAQ:RIGL)

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced the appointments of Eric K. Rowinsky, M.D. and Amy W. Schulman to the company’s board of directors. Together the significant insights and expertise of these two industry leaders will help to guide BIND’s management team in the achievement of its business and development goals. BIND Therapeutics, … Continue reading Stocks in Focus : BIND Therapeutics (NASDAQ:BIND), Bristol-Myers Squibb (NYSE:BMY), TC PipeLines (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals (NASDAQ:RIGL)

Jayne Crisman
Finance

Stocks in Focus: BIND Therapeutics, Inc. (NASDAQ:BIND), Bristol-Myers Squibb Company (NYSE:BMY), TC PipeLines, LP (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced the appointments of Eric K. Rowinsky, M.D. and Amy W. Schulman to the company’s board of directors. Together the significant insights and expertise of these two industry leaders will help to guide BIND’s management team in the achievement of its business and development goals. BIND Therapeutics, … Continue reading Stocks in Focus: BIND Therapeutics, Inc. (NASDAQ:BIND), Bristol-Myers Squibb Company (NYSE:BMY), TC PipeLines, LP (NYSE:TCP), Entergy Corporation (NYSE:ETR), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Kristen Barton
Finance

Losers to Watch: USEC (NYSE:USU), NQ Mobile (NYSE:NQ), Manhattan Bridge Capital (NASDAQ:LOAN), BIND Therapeutics (NASDAQ:BIND), You On Demand (NASDAQ:YOD)

The shares of USEC Inc. (NYSE:USU) is rising after news of its 8-K filing with the Securities and Exchange Commission (SEC) regarding new funding, of $2.5 million, from the US Department of Energy (DOE). The funding comes following an amendment to an agreement with a research lab operator for further research on American Centrifuge technology. USEC Inc. (NYSE:USU) stock performance was -33.61% in last session … Continue reading Losers to Watch: USEC (NYSE:USU), NQ Mobile (NYSE:NQ), Manhattan Bridge Capital (NASDAQ:LOAN), BIND Therapeutics (NASDAQ:BIND), You On Demand (NASDAQ:YOD)

Ryan Holtz
Finance

Healthcare Gainers: USMD Holdings (NASDAQ:USMD), InfuSystem Holdings (NYSEMKT:INFU), TearLab (NASDAQ:TEAR), BIND Therapeutics (NASDAQ:BIND)

USMD Holdings, Inc.’s (USMD) rating falls this week to an F (“strong sell”), down from last week’s D (“sell”). In Portfolio Grader’s specific subcategories of Earnings Growth and Margin Growth, USMD also gets F’s. Shares of the stock have been trading at an exceptionally rapid pace, up fourfold from the week prior. USMD Holdings Inc (NASDAQ:USMD) stock performance was 6.70% in last session and finished … Continue reading Healthcare Gainers: USMD Holdings (NASDAQ:USMD), InfuSystem Holdings (NYSEMKT:INFU), TearLab (NASDAQ:TEAR), BIND Therapeutics (NASDAQ:BIND)

Jason Knox
Finance

Biotech Volatile Stocks: BIND Therapeutics (NASDAQ:BIND), Oncomed Pharmaceuticals Inc (NASDAQ:OMED), Advaxis (NASDAQ:ADXS), Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

BIND Therapeutics, Inc. (NASDAQ:BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced it will report fourth quarter and year ended December 31, 2013 financial results on Tuesday, March 25, 2014. BIND Therapeutics Inc (NASDAQ:BIND) stock performance was 7.75% in last session and finished the day at $12.93. Traded volume was 259,387million shares in the last session and the average … Continue reading Biotech Volatile Stocks: BIND Therapeutics (NASDAQ:BIND), Oncomed Pharmaceuticals Inc (NASDAQ:OMED), Advaxis (NASDAQ:ADXS), Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

Chris Lewis